Catalog

Multiple sclerosis (MS) is the most common, non-traumatic cause of central nervous system (CNS) disability in adults. In the United States approximately 400,000 people are affected by MS, with approximately 2.5 million affected worldwide. The cause of MS is not known, though it is believed that an environmental trigger initiates an autoimmune event, creating disease in genetically-sensitive people. Women are twice as likely as men to be diagnosed with MS, with most patients presenting with symptoms in their late twenties or early thirties. This educational program is designed to give PAs an overview of MS and to provide much needed education to support the complex management of patients with MS and allow PAs to more effectively collaborate with neurology specialists. Additional training in MS is important for PAs because of their role in health care maintenance and to support patients when MS specialists are not accessible. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.

Multiple sclerosis (MS) is the most common, non-traumatic cause of central nervous system (CNS) disability in adults. In the United States approximately 400,000 people are affected by MS, with approximately 2.5 million affected worldwide. The cause of MS is not known, though it is believed that an environmental trigger initiates an autoimmune event, creating disease in genetically-sensitive people. Women are twice as likely as men to be diagnosed with MS, with most patients presenting with symptoms in their late twenties or early thirties. This educational proposal is designed to give PAs an overview of MS and to provide much needed education to support the complex management of patients with MS and allow PAs to more effectively collaborate with neurology specialists. Additional training in MS is important for PAs because of their role in health care maintenance and to support patients when MS specialists are not accessible. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.

Multiple sclerosis (MS) is the most common, non-traumatic cause of central nervous system (CNS) disability in adults. In the United States approximately 400,000 people are affected by MS, with approximately 2.5 million affected worldwide. The cause of MS is not known, though it is believed that an environmental trigger initiates an autoimmune event, creating disease in genetically-sensitive people. Women are twice as likely as men to be diagnosed with MS, with most patients presenting with symptoms in their late twenties or early thirties. This educational proposal is designed to give PAs an overview of MS and to provide much needed education to support the complex management of patients with MS and allow PAs to more effectively collaborate with neurology specialists. Additional training in MS is important for PAs because of their role in health care maintenance and to support patients when MS specialists are not accessible. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.

This program is for PAs who want to advance their careers in areas of clinical and nonclinical medicine by pursuing advanced study. The curriculum focuses on various leadership and management subjects to prepare you to pursue additional study toward an advanced degree.

An Update on Expanding HIV Preexposure Prophylaxis | Wellens Syndrome: An Important Consideration in Patients With Chest Pain

To treat heart failure (HF) effectively, symptoms must first be recognized and followed with an appropriate, timely diagnosis. As well, guideline-directed management must be implemented. The implementation of these recommendations is crucial for maximizing the benefits of HF therapy in clinical practice. Similarly, type 2 diabetes is frequently comorbid with HF, so both conditions require effective co-management. SGLT-2 inhibitors are now indicated for patients with and without diabetes to treat HF, and PAs need to be aware of these new indications. These areas were identified as foundational areas that require additional education. This program is specifically designed to address these gaps and to promote care that will lead to better patient outcomes among patients with HF. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.

To treat heart failure (HF) effectively, symptoms must first be recognized and followed with an appropriate, timely diagnosis. As well, guideline-directed management must be implemented. The implementation of these recommendations is crucial for maximizing the benefits of HF therapy in clinical practice. Similarly, type 2 diabetes is frequently comorbid with HF, so both conditions require effective co-management. SGLT-2 inhibitors are now indicated for patients with and without diabetes to treat HF, and PAs need to be aware of these new indications. These areas were identified as foundational areas that require additional education. This program is specifically designed to address these gaps and to promote care that will lead to better patient outcomes among patients with HF. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.

To treat heart failure (HF) effectively, symptoms must first be recognized and followed with an appropriate, timely diagnosis. As well, guideline-directed management must be implemented. The implementation of these recommendations is crucial for maximizing the benefits of HF therapy in clinical practice. Similarly, type 2 diabetes is frequently comorbid with HF, so both conditions require effective co-management. SGLT-2 inhibitors are now indicated for patients with and without diabetes to treat HF, and PAs need to be aware of these new indications. These areas were identified as foundational areas that require additional education. This program is specifically designed to address these gaps and to promote care that will lead to better patient outcomes among patients with HF. Through the tactical combination of online and print formats, this program will appeal to various learning styles and allow participants to reinforce their knowledge and acquire new skills that can immediately be applied to clinical practice.

This podcast series explores the challenges in colorectal screening and how to improve screening rates by reviewing data on causes, incidence rates, and risk factors. This series will cover recommendations and guidance for screening, compare and contrast available screening options, patient communication and more.

This is the first episode of a three-part podcast series focused on reviewing data on causes, incidence rates, and risk factors associated with colorectal cancer and reflecting on how this pertains to their clinical practices. This podcast will also describe the latest recommendations and guidance for screening and its role in preventing progressive disease, and review the various guidelines on CRCS.